Dowling & Yahnke LLC
- SEC CIK
- 0001133197
- Latest filing
- Nov 3, 2022
RGLS holding history
Regulus Therapeutics Inc. in every 13F filed by Dowling & Yahnke LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RGLS overviewAll 13F holders of RGLSFull Q3 2022 holdings
- Shares (Q2 2022)
- 0
- Sold out in Q2 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2022 | 0 | $0 | 0.0% | −1,200−100.0% | Sold outConverted for a 1-for-10 split | Holders |
| Q1 2022 | 12,000 | $4.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 12,000 | $4.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 12,000 | $8.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 12,000 | $10.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 12,000 | $19.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.